Gilead Sciences, Inc. (NASDAQ:GILD) Q3 earnings release is on October 28, 2014. Many question Gilead Sciences, Inc. (NASDAQ:GILD)’s “$1000 wonder…
Browsing: BioPharma
322
Gilead Sciences, Inc. (NASDAQ:GILD) Expansion Plans & $1000-Miracle Hepatitis C Drug Sovaldi
227
Roche Holdings AG (VTX:ROG) To Purchase InterMune Inc (NASDAQ:INTM) for $8.3 Billion
The Swiss pharmaceutical company, Roche Holdings AG (VTX:ROG) will pay $8.3 billion in cash to buy InterMune Inc (NASDAQ:INTM). InterMune…
595
Ukrainian Unrest Stirs Wall Street – Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Kate Spade and Co (NYSE:KATE) and NII Holdings Inc (NASDAQ:NIHD)
The tense state of affairs in Ukraine is being felt by the US market as well; the current situation brought…
616
The Very Recent Surprises and Disappointments on Wall Street – Ply Gem Holdings Inc. (NYSE: PGEM), Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX), Post Holdings Inc. (NYSE: POST), Emulex Corporation (NYSE: ELX) and Sotheby’s (NYSE: BID)
According to Wall Street analyses, the companies that have succeeded in topping the charts midday on the 8th of August,…
232
Hanger Inc. (NYSE:HGR) Misses the Estimates- Stocks on A Fall
Hanger Inc. (NYSE:HGR), one of the leading United States companies that provides both orthotic and prosthetic care services to its clients,…
543
What’s Hot on Investors List: Professional Diversity Network LLC (NASDAQ:IPDN), ShoreTel, Inc. (NASDAQ:SHOR), VirtualScopics Inc. (NASDAQ:VSCP), Tonix Pharmaceuticals (NASDAQ:TNXP), SMTP (NASDAQ:SMTP)
ShoreTel Inc (NASDAQ:SHOR) recorded an improvement in its financial position this quarter as announced by the company on 7th August;…